Your search for "vector" return 31 results.
ProBioGen and Ceva Santé Animale sign an exclusive license agreement to produce vectorised poultry vaccines using AGE1.CR® production technology >
Berlin, Germany and Libourne, France 01st October 2019 - ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines...
IPPE 2019 – Ceva’s latest innovations offer producers greater performance optimisation from the hatchery >
7th February 2019, Altanta, USA - In 2019, Ceva will introduce several notable additions to its Vaccinology range of products, equipment and services drawing from the 9 Innovation Areas introduced in...
Ceva launches a “new wave of innovation” with new technology vaccines >
Ceva launches a “new wave of innovation” to help poultry producers meet the performance challenges driven by the need for “No antibiotics” and more sustainable production
Ceva consolidates its position as the leading French player in the global animal health market >
Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market
Ceva stresses the need for continued innovation to ensure effective disease control at IPPE 2017 >
Vectormune® ND, vaccine for Newcastle Disease (ND) Cevac IBird®, for Infectious Bronchitis (IB) prevention will continue to lead offerings for effective and easily administered disease control.
Ceva sponsors the International Symposium on Marek’s Disease and Avian Herpes viruses organised by INRA, France >
11th International Symposium on Marek’s Disease and Avian Herpes viruses organized in Tours, France
Ceva to showcase latest hatchery innovations during World Veterinary Poultry Association congress >
Libourne 31th August 2015 – The XIXth World Veterinary Poultry Association (WVPA) congress takes place on September (7th- 11th) in Cape Town, South Africa with Ceva as a diamond sponsor. The congress...
Ceva’s new generation Vectormune® AI vaccine proves to be a useful tool to control HPAI >
A paper* recently published in the peer-reviewed journal Vaccine** reports that Ceva’s new generation vaccine, Vectormune® AI, offers significant advantages over previously available vaccines against...
Egypt study confirms that a single rHVT-H5 hatchery vaccination could be an effective tool to address A/H5N1 prevention >
Research confirms that in endemic countries the classical inactivated vaccines are less effective and hard to administer, while application of a rHVT vector hatchery vaccine is labour saving, cost eff...
Ceva calls for more action “together” to overcome Avian Influenza >
Latest Poultry Vaccinology Summit in Mexico focuses on Avian influenza